WTW Expands Wealth Business with Launch of Via Retirement WTW (NASDAQ: $WTW), a global advisory, broking and solutions company, has launched Via Retirement in the US, expanding its wealth business with a new offering designed to support individuals as they transition from saving for retirement to managing their finances in retirement. The offering combines WTW’s retirement and investment expertise with personalised advice and technology to address evolving retirement needs. Read the full release: globenewswire.com/news-relea… #WTW #WealthManagement #RetirementPlanning #FinancialServices #IEC #InvestorRelations

Amber International Holding Limited Announces Results of its Annual General Meeting @ambergroup_io (NASDAQ: $AMBR) has announced the results of its Annual General Meeting held in Singapore on October 23, 2026. Shareholders approved several resolutions, including: • A one-time incentive award of 23,469,189 Class B ordinary shares to Michael Wu, to be fully vested and issued on October 23, 2026. • Board appointments, including Michael Wu as Chairman, alongside five additional director appointments. • Amendments to the Company's Post-IPO Share Incentive Plan, including an increase in the share reserve to 11 million Class A ordinary shares. Read the full press release: prnewswire.com/news-releases… #AMBR #CorporateGovernance #InvestorRelations #AmberInternational

#IPO Gravitics just cut its proposed IPO raise by 60%. But anyone hoping the shares got a 60% discount will be disappointed: the proposed 14–17 range is still there. The Washington cargo spacecraft developer is now seeking $50 million instead of $125 million. It also has a $270 million Axiom Space contract to deliver, so there’s still a very expensive job to pay for. A smaller offering could still work. The uncomfortable part is how much of the new money already has somewhere to go before the engineers get very far. A share can keep the same price while the company gets less cash to execute. But prospective investors deserve to know which milestones the smaller raise can buy, and whether those milestones release enough customer money to keep going. Our full article below follows the cash past the IPO headline here: linkedin.com/pulse/gravitics… #Gravitics #IPOAnalysis #SpaceFinance #IPONews #IPOMarket #InvestorRelations #AxiomSpace #SpaceX

MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN MacroGenics, Inc. (NASDAQ: $MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced positive interim data from its Phase 1 study evaluating MGC026, a B7-H3-directed antibody-drug conjugate (ADC), in patients with advanced solid tumors. These Phase 1 data were presented today at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain. These results demonstrated durable activity across a broad range of solid tumors, which the Company believes supports expanded development of MGC026 in front-line metastatic squamous cell carcinoma of the head and neck (SCCHN) in combination with pembrolizumab. Read full press here: globenewswire.com/news-relea… #MacroGenics #Biotechnology #Oncology #ClinicalTrials #IEC #InvestorRelations

Peloton Interactive, Inc. Announces Date of First Quarter Fiscal 2027 Earnings Release and Conference Call Peloton Interactive, Inc. (NASDAQ: $PTON) will release its first quarter fiscal 2027 financial results before the U.S. stock market opens on Thursday, November 5, 2026. The company will host a conference call and live audio webcast to discuss the financial results at 8:30 a.m. (Eastern Time) that day. Peloton’s management will answer select questions from retail and institutional investors that are related to the company’s business updates and quarterly financial results. If you would like to submit a question for consideration, please use the questionnaire form. Read full release here: globenewswire.com/news-relea… #Peloton #NASDAQ #EarningsAnnouncement #InvestorRelations #IEC #InvestorRelations

#Investing If you already own a piece of a factory, you’re probably going to have a few opinions when someone proposes selling part of it on another continent. Shareholders in Simwon America’s two Korean-listed parents are now getting that conversation. The California Tesla supplier has filed for a $50 million Nasdaq IPO, with some proceeds intended for expansion. Fresh capital could help Simwon grow, and everyone knows it. But existing shareholders have to work out what they’re giving up and what they’re getting in return. Not to mention, Korea’s new rules require the parents to make that case and hear shareholders out. Simwon’s filing says no overseas listing had yet been reviewed under them. The parent boards vote October 20, after the people who already have money riding on this factory have had a chance to weigh in. Tesla, responsible for about 99% of Simwon’s sales, also reports earnings the next day. Read the full story below from both sides of the Pacific here: linkedin.com/pulse/tesla-sup… #SimwonAmerica #CrossBorderIPO #TSLA #Tesla #CorporateGovernance #IPO #IPOUpdate #IPOMarket #InvestorRelations #IPONews

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar INmune Bio Inc. (NASDAQ: $INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB). INmune Bio initially intends to use the framework to pursue named-patient access in selected European countries and in the Middle East and North Africa (MENA), subject to applicable law and country-specific statements of work. The relationship may subsequently expand across Europe and other territories by mutual agreement. Read full release here: globenewswire.com/news-relea… #INMB #Biotechnology #RareDiseases #GlobalCommercialization #IEC #InvestorRelations

Duos Technologies to Participate in the 20th Annual LD Micro Main Event Duos Technologies Group, Inc. (Nasdaq: $DUOT), a provider of adaptive, modular architecture data center colocation and infrastructure solutions, today announced that it will participate in the 20th Annual LD Micro Main Event being held from October 19-21, 2026 at the Luxe Sunset Blvd Hotel in Los Angeles, CA. Duos management will host a presentation on Tuesday, October 20 at 1:00 p.m. Pacific Time. The presentation will be webcast and available for replay here. Read full release here: globenewswire.com/news-relea… #DuosTechnologies #DataCenterInfrastructure #InvestorRelations #SmallCapStocks #IEC #InvestorRelations

Ten years of building relationships in capital markets. Many companies served. And this week our team is at @TechCrunch Disrupt 2026 in San Francisco, standing in front of 10,000 of the world’s most ambitious founders and investors, showing what a decade of that work looks like when you build it into a platform. Proud does not cover it. Go find the @AllinAI_US team in the Expo Hall if you are there today. #TCDisrupt #IECCapital #AllinAI #StartupBattlefield #Fintech #CapitalMarkets

Chaince Securities, LLC to Serve as Exclusive Sales Agent for CL Workshop Group Limited’s (NASDAQ: $NWGL) Up to US$200 Million At-the-Market Offering Program Chaince Securities, LLC (“Chaince”), a FINRA-registered broker-dealer and wholly owned subsidiary of Chaince Digital Holdings Inc. (NASDAQ: $CD), today announced that it has been engaged as the exclusive sales agent for the at-the-market (“ATM”) equity offering program of CL Workshop Group Limited (NASDAQ: NWGL) (the “Company”), a British Virgin Islands-incorporated holding company headquartered in Macau whose operations are conducted in Peru, France and Macau through its operating subsidiaries and which is principally engaged in forest management, harvesting, and the processing, manufacturing and distribution of wood products. Read full release here: globenewswire.com/news-relea… #ATMOffering #CapitalMarkets #NASDAQ #EquityFinancing #IEC #InvestorRelationships

Atlas Trinity Tech Limited Announces Appointment of Mr. Haoyuan Liu as Chief Executive Officer Atlas Trinity Tech Limited (the “Company”) (Nasdaq: $ATTT) today announced that its Board of Directors (the “Board”) has appointed Mr. Haoyuan Liu as Chief Executive Officer of the Company, effective October 15, 2026. Mr. Liu will succeed Mr. Tim Hoi Ching, who will step down as Chief Executive Officer on the same date and will continue to serve as an Executive Director of the Company. Read the full release here: globenewswire.com/news-relea… #LeadershipChange #ExecutiveAppointment #CorporateGovernance #NASDAQ

Cycurion Relaunches as a Predictive Cybersecurity Company, Powered by AI and Led by Former Intelligence Community and Private-Sector Cyber Experts Cycurion, Inc. (Nasdaq: $CYCU), a trusted leader in IT cybersecurity and AI-driven solutions, today relaunched as a predictive cybersecurity company, built around a newly assembled team of former U.S. Intelligence Community and private-sector cyber experts. Instead of racing to clean up after a breach, Cycurion is building AI-driven technology designed to see an attack forming and help stop it before operations are touched. The first capability is expected in the coming weeks. The standard is simple to say and hard to meet: see the attack before it surfaces. Read the full press release here: globenewswire.com/news-relea… #Cybersecurity #ArtificialIntelligence #NASDAQ #InvestorRelations #IEC

Our team is on the floor at @TechCrunchPlus Disrupt 2026. Over a decade of investor relations work at IEC taught us one thing: capital access is an information problem. When verified information is hard to find, capital follows networks rather than merit. @AllinAI_US is our answer. Founded by our own @annabelle_host, the Capital Brain keeps a sourced, always current picture of a company and brings it to the investors, analysts and media who should see it. When an investor passes, it works out what would change the answer and goes again. This week our Allin AI team is at Moscone West with the Startup Battlefield 200. If you're at Disrupt, go and find them. #TCDisrupt #StartupBattlefield #InvestorRelations #CapitalMarkets #Fintech #AI

Uniti Solutions Launches Managed AI Security to Help Businesses Combat AI Cyber Risks Uniti Solutions, the leading provider of telecom infrastructure solutions, has launched an “AI Security” offering, powered by Cato Networks, to help business customers combat a new landscape of cyber risks created internally by unsecured employee AI use. AI is rapidly becoming part of everyday business operations, but much of its use remains difficult for organizations to govern. OpenAI reports that more than 2 million* business customers now use its tools, while Microsoft and LinkedIn found that 78%** of AI users bring their own AI tools to work. Read full release here: globenewswire.com/news-relea… #AISecurity #Cybersecurity #ArtificialIntelligence #EnterpriseTechnology #IEC #InvestorRelations

#Biotech In 2007, 40 people in Germany took an experimental blood-pressure pill called SLx-2101. Then the drug more or less disappeared. Its labmate went on to become Rezurock, win FDA approval, and help sell Kadmon to Sanofi for $1.9 billion. But SLx-2101 got no such victory lap. It sat on the shelf, changed hands, was eventually returned to members of its original development orbit and, years later, moved into another company for $1. Now it has a new name, RTN-001, a new formulation, a new clinical trial and, 19 years after those first patients swallowed it, a date with Wall Street. Biotech is full of comeback stories. Few come with this much baggage, this many corporate owners, or a dollar bill buried in the paperwork. We traced the entire strange journey from a tiny 2007 trial to today. Full story here: linkedin.com/pulse/blood-pre… #DrugDevelopment #LifeSciences #BiotechIPO #BiotechInvesting #CapitalMarkets #Nasdaq #InvestorRelations

Axonex AI Group Limited (NASDAQ: $AXNX) Solidifies Transformation into an AI and Robotics-Focused Company Mint Incorporation Limited today announced that it has changed the Company's name to Axonex AI Group Limited (“Axonex AI” or the “Company”, together with its subsidiaries, the “Group”), as part of its official rebranding. The change of name took effect on September 28, 2026. The Company's Class A ordinary shares are expected to begin trading on the Nasdaq Capital Market under the new ticker symbol “AXNX”, at the open of market trading on October 13, 2026. The CUSIP number for the Class A ordinary shares remains unchanged. The new corporate website is now live at axonexai.com. Read the full release here: globenewswire.com/news-relea… #ArtificialIntelligence #Robotics #NASDAQ #CorporateTransformation #IEC #InvestorRelations